Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;7(3):274-278.
doi: 10.1089/can.2022.0006. Epub 2022 May 24.

Contribution of G Protein-Coupled Receptor 55 to Periaqueductal Gray-Mediated Antinociception in the Inflammatory Pain

Affiliations

Contribution of G Protein-Coupled Receptor 55 to Periaqueductal Gray-Mediated Antinociception in the Inflammatory Pain

Henry Blanton et al. Cannabis Cannabinoid Res. 2022 Jun.

Abstract

The brain mechanism of inflammatory pain is an understudied area of research, particularly concerning the descending pain modulatory system. The G protein-coupled receptor 55 (GPR55) is a lysophosphatidylinositol-sensitive receptor that has also been involved in cannabinoid signaling. It is widely expressed throughout the central nervous system, including the periaqueductal gray (PAG), a brainstem area and key element of the descending pain modulatory system. In this study, we used behavioral, stereotaxic injections, pharmacological tools, and two inflammatory pain models (formalin and carrageenan) to determine if GPR55 in the PAG plays a role in the pain associated with inflammation in rats. It was found that the blockade of GPR55 action in PAG can drive the descending pain modulatory system to mitigate inflammatory pain. These data show that GPR55 plays a role in the descending pain modulatory system in inflammatory pain.

Keywords: GPR55; cannabinoids; descending pain modulatory system; inflammatory pain; periaqueductal gray.

PubMed Disclaimer

Conflict of interest statement

No competing financial interests exist.

Figures

FIG. 1.
FIG. 1.
The design of the experiment (A). PAG pretreatment with ML-193 reduced the second phase (C) of formalin-induced pain-like behaviors, but not the first phase (B). Illustration of cannula placement, site of action, and schematic representation of targeted (Bregma −7.32 mm) (D). Intraplantar injection of ML-193 (0.1–1 μg) did not affect formalin induced pain-like behaviors (E, F). SR141716A and SR 144528 failed to affect the analgesic effect of ML-193 (G, H). Data are presented as mean±SEM. **p<0.01, *p<0.05 (ML-193 vs. vehicle). PAG, periaqueductal gray; ns, not significant.
FIG. 2.
FIG. 2.
The design of the experiment (A). PAG pretreatment with ML-193 reduced the mechanical allodynia (B) and thermal hypersensitivity (C) induced by carrageenan. SR141716A and SR 144528 failed to affect the analgesic effect of ML-193 in carrageenan-induced mechanical allodynia (D) and thermal hypersensitivity (E). Data are presented as mean±SEM. ***p<0.001. ns, not significant.

Similar articles

Cited by

References

    1. Fields HL, Heinricher MM, Mason P. Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci. 1991;14:219–245. - PubMed
    1. Ossipov MH, Lai J, Malan TP Jr. et al. Spinal and supraspinal mechanisms of neuropathic pain. Ann N Y Acad Sci. 2002;909:12–24. - PubMed
    1. Heinricher MM, Tavares I, Leith JL, et al. . Descending control of nociception: specificity, recruitment and plasticity. Brain Res Rev. 2009;60:214–225. - PMC - PubMed
    1. Porreca F, Ossipov MH, Gebhart GF. Chronic pain and medullary descending facilitation. Trends Neurosci. 2002;25:319–325. - PubMed
    1. Henstridge CM, Balenga NA, Kargl J, et al. . Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55. Mol Endocrinol. 2011;25:1835–1848. - PMC - PubMed

Publication types

Substances